Toll-like receptor 2 expression on human conjunctival epithelial cells: A pathway for Staphylococcus aureus involvement in chronic ocular proinflammatory responses

Annals of Allergy, Asthma and Immunology

Volumn 94, Issue 4, 2005, Pages 486-497

  Cook, Ellen B ^a,b   Stahl, James L ^a   Esnault, Stéphane ^a   Barney, Neal P ^a   Graziano, Frank M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MESSENGER RNA; RECEPTOR ANTIBODY; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ATOPIC KERATOCONJUNCTIVITIS; CADAVER; CELL ACTIVATION; CELL ISOLATION; CONJUNCTIVA EPITHELIUM; CONJUNCTIVITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; EYE INFLAMMATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMPRESSION CYTOLOGY; PRIORITY JOURNAL; SEASONAL ALLERGIC CONJUNCTIVITIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UPREGULATION;

EID: 17444420662     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61120-9     Document Type: Article

References (42)

1. Nakata K, Inoue Y, Harada J, et al. A high incidence of Staphylococcus aureus colonization in the external eyes of patients with atopic dermatitis. Ophthalmology. 2000;107:2167-2171.
2. Tuft SJ, Ramakrishnan M, Seal DV, Kemeny DM, Buckley RJ. Role of Staphylococcus aureus in chronic allergic conjunctivitis. Ophthalmology. 1992;99:180-184.
3. Nomura I, Goleva E, Howell MD, et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. Immunology. 2003;171:3262-3269.
4. Toshitani A, Imayama S, Shimozono Y, Yoshinga I, Fukue M, Hori Y. Reduced amount of secretory component of IgA secretion in tears of patients with atopic dermatitis. J Dermatol Sci. 1999;19:134-138.
5. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem. 1999;274: 17406-17409.
6. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999;11:443-451.
7. Aliprantis AO, Yang RB, Mark MR, et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science. 1999;285:736-739.
8. Brightbill HD, Libraty DH, Krutzik SR, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 1999;285:732-736.
9. Uehara A, Sugawara S, Tamai R, Takada H. Contrasting responses of human gingival and colonic epithelial cells to lipopolysaccharide, lipoteichoic acids and peptidoglycans in the presence of soluble CD14. Med Microbiol Immunol. 2001;189:185-192.
10. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000;68:7010-7017.
11. Song PI, Abraham TA, Park Y, et al. The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells. Invest Ophthalmol Vis Sci. 2001;42:2867-2877.
12. Wolfs TG, Buurman WA, van Schadewijk A, et al. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-γ and TNF-α mediated up-regulation during inflammation. J Immunol. 2002;163:1286-1293.
13. Abreu MT, Arnold ET, Thomas LS, et al. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem. 2002;277:20431-20437.
14. Tsuboi N, Yoshikai Y, Matsuo S, et al. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol. 2002;169:2026-2033.
15. Pivarcsi A, Bodai L, Réthi B, et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol. 2003;15:721-730.
16. Mempel M, Voelcker V, Köllisch G, et al. Toll-like receptor expression in human keratinocytes: nuclear factor κB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol. 2003;121:1389-1396.
17. Lemjabbar H, Basbaum C. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat Med. 2002;8:41-46.
18. Travers JB, Leung DY, Johnson C, et al. Augmentation of staphylococcal α-toxin signaling by the epidermal platelet-activating factor receptor. J Invest Dermatol. 2003;120:789-794.
19. Kumar A, Ahang J, Yu FX. Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion. Invest Ophthalmol Vis Sci. 2004;45:3513-3522.
20. Hingorani M, Calder V, Buckley RJ, Lightman SL. The role of conjunctival epithelial cells in chronic ocular allergic disease. Exp Eye Res. 1998;67:491-500.
21. Fujishima H, Saito I, Takeuchi T, Tsubota K. Immunological characteristics of patients with vernal keratoconjunctivitis. Jpn J Ophthalmol. 2002;46:244-248.
22. Baudouin C, Brignole F, Becquet F, Pisella PJ, Goguel A. Flow cytometry in impression cytology specimens: a new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci. 1997;38:1458-1464.
23. Baudouin C, Haouat N, Brignole F, Bayle J, Gastaud P. Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens. Br J Ophthalmol. 1992;76:545-549.
24. Oh JW, Shin JC, Jang SJ, Lee HB. Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitis. Ann Allergy Asthma Immunol. 1999;82:579-585.
25. Miyoshi T, Fukagawa K, Shimmura S, et al. Interleukin-8 concentrations in conjunctival epithelium brush cytology samples correlate with neutrophil, eosinophil infiltration, and corneal damage. Cornea. 2001;20:743-747.
26. Calder VL, Jolly G, Hingorani M, et al. Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease. Clin Exp Allergy. 1999;29:1214-1222.
27. Metz DP, Hingorani M, Calder VL, Buckley RJ, Lightman SL. T-cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol. 1997;100:817-824.
28. Stahl JL, Cook EB, Graziano FM, Barney NP. Differential and cooperative effects of TNFα, IL-1β and IFNγ on human conjunctival epithelial cell receptor expression and chemokine release. Invest Ophthalmol Vis Sci. 2003;44:2010-2015.
29. Uehara A, Sugawara S, Takada H. Priming of human oral epithelial cells by interferon-γ to secrete cytokines in response to lipopolysaccharides, lipoteichoic acids and peptidoglycans. J Med Microbiol. 2002;51:626-634.
30. Cook EB, Stahl JL, Miller S, et al. Isolation of human conjunctival mast cells and epithelial cells: tumor necrosis factor-α from mast cells affects intercellular adhesion molecule 1 expression on epithelial cells. Invest Ophthalmol Vis Sci. 1998;39:336-343.
31. Esnault S, Malter JS. Granulocyte macrophage-colony-stimulating factor mRNA is stabilized in airway eosinophils and peripheral blood eosinophils activated by TNF-α plus fibronectin. J Immunol. 2001;166:4658-4663.
32. Brignole-Baudouin F, Ott AC, Warnet JM, Baudouin C. Flow cytometry in conjunctival impression cytology: a new tool for exploring ocular surface pathologies. Exp Eye Res. 2004;78:473-481.
33. Suzuki M, Hisamatsu T, Podolsky DK. γ Interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex. Infect Immun. 2003;71:3503-3511.
34. Travassos LH, Girardin SE, Philpott DJ, et al. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 2004;5:1000-1006.
35. Kato M, Kurose T, Oda T, Miyaji S. The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis. J Ocul Pharmacol Ther. 2003;19:315-324.
36. Kato M, Imoto K, Miyake H, Oda T, Miyaji S, Nakamura M. Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs. J Pharmacol Sci. 2004;95:435-442.
37. Yanni JM, Stephens DJ, Miller ST, et al. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/ antihistaminic agent. J Ocul Pharmacol Ther. 1996;12:389-400.
38. Talreja J, Kabir MH, B Filla M, Stechschulte DJ, Dileepan KN. Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to gram-positive and gram-negative bacterial cell wall components. Immunology. 2004;113:224-233.
39. Szakos E, Lakos G, Aleksza M, et al. Relationship between skin bacterial colonization and the occurrence of allergen-specific and non-allergen-specific antibodies in sera of children with atopic eczema/dermatitis syndrome. Acta Derm Venereol. 2004; 84:32-36.
40. Arima Y, Nakai Y, Hayakawa R, Nishino T. Antibacterial effect of β-thujaplicin on staphylococci isolated from atopic dermatitis: relationship between changes in the number of viable bacterial cells and clinical improvement in an eczematous lesion of atopic dermatitis. J Antimicrob Chemother. 2003;51:113-122.
41. Breuer K, Haussler S, Kapp A, Werfel T. Staphylococcus aureus: colonizing features and influence of antibacterial treatment in adults with atopic dermatitis. Br J Dermatol. 2002;147:55-61.
42. Nivenius E, Montan PG, Chryssanthou E, et al. No apparent association between periocular and ocular microcolonization and the degree of inflammation in patients with atopic kerato-conjunctivitis. Clin Exp Allergy. 2004;34:725-730.